Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF



GREY:TSTIF - Post by User

Bullboard Posts
Comment by Shoultonon Jul 23, 2014 7:49pm
217 Views
Post# 22775878

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:It doesn't take a full moon to bring out crazy DrCash

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:It doesn't take a full moon to bring out crazy DrCashCan't see why they would put it on hold for details that would not influence the decision. 

https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm089738.pdf

C. Request Additional Information (AI) 

FDA requests AI when the 510(k) submission lacks information necessary for the agency 
to continue or complete the review and to determine whether the device is SE or NSE (21 
CFR 807.87). AI requests may be issued by letter, or may be issued by telephone, fax, or 
e-mail, with a follow-up letter informing the submitter that the 510(k) is being placed on 
hold pending receipt of a response to all of the identified deficiencies. The hold starts on 
the issue date of the detailed AI letter or the letter confirming the hold relating to AI 
issues that were conveyed by telephone, fax or email. 

FDA generally issues an AI request when FDA believes the additional information 
needed from the submitter is not suitable for interactive review and/or cannot be provided 
within a reasonable period of time (i.e., such that the review would be unduly delayed if 
the submission were not placed on hold). 

An AI request is an interim action that stops the review clock and marks the end of an 
FDA review cycle. The review clock will resume upon the receipt of a complete response 
to the AI request in the appropriate Document Control Center. 

***
Bullboard Posts